A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss.
- DOI
- 10.3389/fnins.2022.1024634
- Published
- 2022
- Container
- Frontiers in neuroscience
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fnins.2022.1024634,
title = {A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss.},
author = {Okada M and Ogawa H and Takagi T and Nishihara E and Yoshida T and Hyodo J and Shinomori Y and Honda N and Fujiwara T and Teraoka M and Yamada H and Hirano SI and Hato N},
year = {2022},
journal = {Frontiers in neuroscience},
doi = {10.3389/fnins.2022.1024634},
url = {https://doi.org/10.3389/fnins.2022.1024634}
}RIS
TY - JOUR TI - A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss. AU - Okada M AU - Ogawa H AU - Takagi T AU - Nishihara E AU - Yoshida T AU - Hyodo J AU - Shinomori Y AU - Honda N AU - Fujiwara T AU - Teraoka M AU - Yamada H AU - Hirano SI AU - Hato N PY - 2022 JO - Frontiers in neuroscience DO - 10.3389/fnins.2022.1024634 UR - https://doi.org/10.3389/fnins.2022.1024634 ER -
APA
M, O., H, O., T, T., E, N., T, Y., J, H., Y, S., N, H., T, F., M, T., H, Y., SI, H., & N, H. (2022). A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss.. Frontiers in neuroscience. https://doi.org/10.3389/fnins.2022.1024634
Source records
- pubmed · retrieved 2026-09-25T14:21:30.946Z
- europe-pmc · retrieved 2026-09-25T14:21:30.987Z
- doaj · retrieved 2026-09-25T14:21:30.952Z